Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Mol Biol Rep ; 39(2): 887-93, 2012 Feb.
Article in English | MEDLINE | ID: mdl-21630102

ABSTRACT

Alterations in folate metabolism may contribute to the process of carcinogenesis by influencing DNA methylation and genomic stability. Polymorphisms in genes encoding enzymes involved in this pathway may alter enzyme activity and consequently interfere in concentrations of homocysteine and S-adenosylmethionine that are important for DNA synthesis and cellular methylation reactions. The objectives were to investigate MTHFD1 G1958A, BHMT G742A, TC2 C776G and TC2 A67G polymorphisms involved in folate metabolism on head and neck cancer risk and the association between these polymorphisms with risk factors. Polymorphisms were investigated in 762 individuals (272 patients and 490 controls) by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and Real Time-PCR. Chi-square and Multiple logistic regression were used for the statistical analysis. Multiple logistic regression showed that tobacco and male gender were predictors for the disease (P < 0.05). Hardy-Weinberg equilibrium showed that the genotypic distributions were in equilibrium for both groups in all polymorphisms studied. The BHMT 742GA or AA genotypes associated with tobacco consumption (P = 0.016) increase the risk for head and neck squamous cell carcinoma (HNSCC). The present study suggests that BHMT 742GA polymorphism associated to tobacco modulate HNSCC risk. However, further investigation of gene-gene interactions in folate metabolism and studies in different populations are needed to investigate polymorphisms and HNSCC risk.


Subject(s)
Betaine-Homocysteine S-Methyltransferase/genetics , Carcinoma, Squamous Cell/genetics , Head and Neck Neoplasms/genetics , Methylenetetrahydrofolate Dehydrogenase (NADP)/genetics , Polymorphism, Single Nucleotide/genetics , Transcobalamins/genetics , Brazil/epidemiology , Carcinoma, Squamous Cell/epidemiology , Carcinoma, Squamous Cell/metabolism , DNA Methylation/genetics , Female , Folic Acid/metabolism , Genomic Instability/genetics , Head and Neck Neoplasms/epidemiology , Head and Neck Neoplasms/metabolism , Humans , Logistic Models , Male , Minor Histocompatibility Antigens , Polymerase Chain Reaction , Polymorphism, Restriction Fragment Length , Risk Factors
2.
Eur J Cancer ; 48(10): 1525-31, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22051736

ABSTRACT

Genetic polymorphisms in folate metabolism may affect the risk of head and neck cancer (HNSCC) due to its involvement in DNA methylation and synthesis. We conducted a case-control study (265 HNSCC cases and 466 non-cancer controls) to investigate associations of MTHFR C677T and A1298C, MTR A2756G, MTRR A66G, RFC1 A80G, MTHFD1 G1958A, CBS 844ins68, TC2 C776G and A67G, SHMT C1420T and BHMT G742A polymorphisms with HNSCC risk. Interactions between polymorphisms and survival time, tobacco and alcohol habits, age, gender and tumour staging (TNM classification) were evaluated by multiple logistic regression analysis. We found that age ≥ 49 years (P<0.001), male gender (P=0.03), tobacco habit (P<0.001), MTHFR 1298AC/CC (P=0.028), MTR 2756AG/GG (P=0.010) and RFC1 80AG/GG (P=0.015) genotypes were associated with an increased risk of HNSCC. There were interactions between lower survival and CBS 844ins68 (P=0.005); age ≥ 49 years and MTR 2756 AG/GG (P=0.004) and RFC1 80AG/GG (P=0.006) genotypes; male gender and MTHFR 1298 AC/CC (P=0.030), MTR 2756 AG/GG (P=0.006) and RFC1 80 AG/GG (P=0.009); tobacco non-habit and MTHFD1 1958GA/AA (P=0.040); tobacco and MTHFR 1298 AC/CC (P=0.054) and MTR 2756 AG/GG (P=0.010); alcohol non-consume and RFC1 80 AG/GG (P=0.008) with HNSCC increased risk. MTHFR C677CT/TT genotypes were less frequently in advanced tumours (P=0.04). In conclusion, our data provide evidence that folate metabolism genetic polymorphisms associated with variables as advanced age, male gender, tobacco and alcohol increase HNSCC development; CBS 844ins68 and MTHFR C677T polymorphisms are associated with less survival time and advanced stage tumours, respectively.


Subject(s)
Carcinoma, Squamous Cell/genetics , Folic Acid/chemistry , Head and Neck Neoplasms/genetics , Methylenetetrahydrofolate Reductase (NADPH2)/genetics , Polymorphism, Genetic , Aged , Alleles , Case-Control Studies , DNA Methylation , Female , Gene Deletion , Genotype , Humans , Male , Middle Aged , Models, Statistical , Regression Analysis , Risk , Squamous Cell Carcinoma of Head and Neck , Time Factors , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL